Navigation Links
AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure

Results expand potential application of key product in AM-Pharma's pipeline

BUNNIK, The Netherlands, 14 March, 2007. AM-Pharma B.V., the biopharmaceutical company developing novel therapeutics to treat infectious and inflammatory diseases, today announced positive results in patients with Acute Renal Failure. The patients involved were a subgroup of a Phase IIa trial with Alkaline Phosphatase to treat Sepsis.

Plasma creatinine clearance, a marker for renal function, improved by 45% (median) in patients with Acute Renal Failure treated with Alkaline Phosphatase and deteriorated by 25% (median) in patients with Acute Renal Failure treated with placebo, with p values of < 0.05.


In addition, the level of glutathione-S-transferase-A1, a marker for kidney damage, decreased by 70% (median) in AP treated patients, compared to a 200% (median) increase in placebo treated patients, with p values again of < 0.05.


Fifteen patients (10 active, 5 placebo) with Acute Renal Failure were treated for 24 hours as part of a double-blind, randomized, placebo-controlled Phase IIa study in 36 Sepsis patients. The study took place in the Department of Intensive Care Medicine at the Radboud University Medical Centre, Nijmegen, The Netherlands.


Bart Wuurman, CEO of AM-Pharma commented on the positive results, saying: "We are very excited by the results in this Acute Renal Failure subgroup. It shows statistically significant and clinically relevant improvements in a condition that is very difficult to treat, has a high mortality rate and is associated with high costs through long term dialysis treatment. We now plan to explore the use of Alkaline Phosphatase in Acute Renal Failure in a separate study."


- ENDS -

Notes to editors:

About AM-Pharma www.am-pharma.com <




Page: 1 2 3

Related medicine technology :

1. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:3/3/2015)... Texas , March 3, 2015  UnaliWear announces ... provides advanced support for seniors that guards against wandering ... The new wearable – the Kanega watch ... its kind to use an easy speech interface rather ... medical information without human input. The ...
(Date:3/3/2015)... -- American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ) a ... in the design, development and production of innovative ... device companies has announced the acquisition of MTI ... cable manufacturer based in North Carolina.  The new ... name MTI Medical Cables.  The ...
(Date:3/3/2015)... Ariz. , March 3, 2015  Michigan brothers ... heart condition called arrhythmogenic right ventricular dysplasia, or ARVD, a ... cause of sudden death among young athletes. In ... at a basketball game. They later tested Dominique and found ... to a February 19, 2015 story in The Ann ...
Breaking Medicine Technology:UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2American Biosurgical Acquires MTI Corporation 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3
(Date:3/4/2015)... Follow us on LinkedIn ... worldwide. The rising prevalence of high blood pressure in ... both developed and developing countries. By 2025, the number ... 1.5 billion, equating to approximately 30% of the total ... to come from the developing countries. Major lifestyle factors ...
(Date:3/4/2015)... March 04, 2015 Developers of FCPX ... a new overlay plugin for Final Cut Pro X entitled ... Overlays Lens Dirt gives users total control over 6k lens ... CEO of Pixel Film Studios. “FCPX Overlays Lens Dirt was ... easy to use interface.” , FCPX Overlays Lens Dirt from ...
(Date:3/4/2015)... March 04, 2015 The medical device ... whose management forgot – or ignored or didn't know ... the market based on physician input before proceeding to ... more specifically, founders – become so enamored of an ... question: Will physicians use the device?” says Dr. ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, Ohio ... District Court for the Northern District of Ohio against ... insurance companies Balboa, QBE, and Newport Management. (See Amended ... , The Plaintiff, a Ms. Dolores Gorsuch, says her ... to buy too much insurance at rates that were ...
(Date:3/3/2015)... March 03, 2015 Longtime parent visionary ... CARE Surrogacy Center for a candid interview ... appearing online is an exhilarating revelation of his magical ... led him from Australia to the birth of his ... interchange, Tolga Umar, CEO and Founder of CARE stated, ...
Breaking Medicine News(10 mins):Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Pixel Film Studios released a New Overlay Plugin entitled FCPX Overlays Lens Dirt Exclusively for Final Cut Pro X users 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3
... HealthDay Reporter , THURSDAY, Dec. 9 (HealthDay News) ... potentially promising weapon against breast cancer recurrence, has flopped ... Zometa did not appear to prevent breast cancer ... researchers presented the disappointing findings Thursday at the San ...
... A new study challenges the theory that lowering the minimum ... binge drinking by college students. Some college presidents and ... bars and restaurants, they might learn more moderate drinking habits, ... college campuses. The idea is being promoted through an effort ...
... Ewa Kuligowska-Noble, MD, FACR, a radiologist at Boston ... Boston University School of Medicine (BUSM), is the recipient ... Association for Women Radiologists. The award, which is presented ... contribution to the field of radiology, was given to ...
... demands on a couple seeking fertility treatment can be daunting. ... fertility to increase a couple,s chances of becoming pregnant in ... Infants Hospital is one of the centers participating in a ... fertility drug. This new drug would require one weekly ...
... By Kathleen Doheny HealthDay Reporter , THURSDAY, ... to counter the prevailing wisdom that any form of hormone ... look at some old data suggests that estrogen-only hormone therapy ... disease. "Exogenous estrogen [such as hormone therapy] is actually ...
... have argued that lowering the minimum legal drinking age could help ... issue of the Journal of Studies on Alcohol and Drugs ... In 2008, a group of college presidents and ... minimum legal drinking age of 21. They argue that the law ...
Cached Medicine News:Health News:Bone Drug Zometa Flops Overall as Breast Cancer Treatment 2Health News:Bone Drug Zometa Flops Overall as Breast Cancer Treatment 3Health News:BMC radiologist receives 2010 Marie Sklodowska-Curie Award from AAWR 2Health News:Estrogen-Only Hormone Therapy May Reduce Breast Cancer Risk for Some 2Health News:Estrogen-Only Hormone Therapy May Reduce Breast Cancer Risk for Some 3Health News:Lowering the drinking age is unlikely to curb college binge drinking 2
Ideal for abdominal procedures...
... in the abdominal area for the taller, ... and eye closures extend the full,length of ... very thin zipper opens the garment completely. ... gripper lace trim, and adjustable detachable straps ...
For lipoplasty of trochanteric region, abdomen, thighs, hips/flanks, buttocks & knees...
White Standard Girdle...
Medicine Products: